表紙
市場調查報告書

全球急性中耳炎治療市場:藥物類別,各劑型,各終端用戶,各地區 - 全球趨勢與預測

Acute Otitis Media Treatment Market, by Drug Type, Formulation, End User, and Region - Global Trends, and Forecast to 2025

出版商 Coherent Market Insights 商品編碼 629622
出版日期 內容資訊 英文 178 Pages
商品交期: 2-3個工作天內
價格
全球急性中耳炎治療市場:藥物類別,各劑型,各終端用戶,各地區 - 全球趨勢與預測 Acute Otitis Media Treatment Market, by Drug Type, Formulation, End User, and Region - Global Trends, and Forecast to 2025
出版日期: 2018年02月23日內容資訊: 英文 178 Pages
簡介

本報告提供全球急性中耳炎治療市場相關調查,彙整市場概要和藥物類別,各劑型,各終端用戶,各地區趨勢,及加入此市場的主要企業簡介等資料。

第1章 與調查目的假設

第2章 市場概要

第3章 市場趨勢,法律規章,趨勢分析

  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 市場機會
  • 影響分析
  • 技術趨勢
  • 未滿足需求
  • 主要的焦點
  • 法律規章方案
  • 近幾年的產品認證/上市
  • PEST分析
  • 波特五力分析

第4章 藥物類別

  • 簡介
  • 抗生劑
  • 非類固醇抗發炎藥物
  • 止痛藥
  • 麻醉劑

第5章 各劑型

  • 簡介
  • 口服
  • 局部

第6章 各流通管道

  • 簡介
  • 醫院
  • 零售藥局
  • 線上藥局

第7章 各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 非洲
  • 中東

第8章 競爭環境

  • 熱圖分析
  • 企業簡介

第9章 章節

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Acute otitis media (AOM) is inflammation of the fluid in the middle ear. AOM is the most common infection and mainly caused in children under the age of 7 years. According to an article published American Family Physician Journal in 2013, around 80% of children will have at least one episode of acute otitis media (AOM) before their school age. AOM is mainly caused by bacteria such as Streptococcus pneumoniae (strep) and Hemophilus influenzae (H. flu) and viruses. Bacteria account for 85% cases of AOM and viruses account for only 15%. AOM is mostly treated with antibiotics usually for 7–10 days and with some analgesic and anesthetic in order to the reduce pain.

Market Dynamics

Increasing prevalence of acute otitis media is expected to be a major driver for growth of the market. Acute otitis media is a very common disease and occurs mostly in children, therefore, increasing prevalence of this disease is expected to increase demand for treatment drugs, thereby positively affecting market growth. According to an article published in The Journal of Laryngology & Otology, in 2013, prevalence of otitis media subtypes is between 7.1–12.8%. Furthermore, recent launches and FDA approvals for new drugs for the treatment of acute otitis media is also expected to drive the market growth in the near future. For instance, in 2015, Otonomy, Inc. received U.S. Food and Drug Administration (FDA) approval for its OTIPRIO (ciprofloxacin otic suspension) indicated for the treatment of pediatric patients with bilateral otitis media with effusion undergoing tympanostomy tube placement. In 2016, Otonomy, Inc. launched OTIPRIO in U.S. market.

Key features of the study:

This report provides in-depth analysis of acute otitis media treatment market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global acute otitis media treatment market  based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans

Key companies covered as a part of this study include Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories, GlaxoSmithKline plc., Bayer AG, Novartis AG, Pediapharm Inc., Sanofi S.A., and Bristol Myers Squibb Company.

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics

The global acute otitis media treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the acute otitis media treatment market

Detailed Segmentation:

  • Global Acute Otitis Media Treatment Market, By Drug Type :
  • Antibiotics
  • Nonsteroidal anti-Inflammatory drug
  • Analgesic
  • Anaesthetic
  • Global Acute Otitis Media Treatment Market, By Formulation:
  • Oral
  • Topical
  • Global Acute Otitis Media Treatment Market, By Distribution Channel:
  • Hospital
  • Retail pharmacies
  • Online pharmacies
  • Global Acute Otitis Media Treatment Market, By Geography:
  • North America
  • By Drug Type :
  • Antibiotics
  • Nonsteroidal anti-Inflammatory drug
  • Analgesic
  • Anaesthetic
  • By Formulation
  • Oral
  • Topical
  • By Distribution Channel:
  • Hospital
  • Retail pharmacies
  • Online pharmacies
  • By Country:
  • U.S.
  • Canada
  • Europe
  • By Drug Type :
  • Antibiotics
  • Nonsteroidal anti-Inflammatory drug
  • Analgesic
  • Anaesthetic
  • By Formulation
  • Oral
  • Topical
  • By Distribution Channel:
  • Hospital
  • Retail pharmacies
  • Online pharmacies
  • By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Drug Type :
  • Antibiotics
  • Nonsteroidal anti-Inflammatory drug
  • Analgesic
  • Anaesthetic
  • By Formulation
  • Oral
  • Topical
  • By Distribution Channel:
  • Hospital
  • Retail pharmacies
  • Online pharmacies
  • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • By Drug Type :
  • Antibiotics
  • Nonsteroidal anti-Inflammatory drug
  • Analgesic
  • Anaesthetic
  • By Formulation
  • Oral
  • Topical
  • By Distribution Channel:
  • Hospital
  • Retail pharmacies
  • Online pharmacies
  • By Country:
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East
  • By Drug Type :
  • Antibiotics
  • Nonsteroidal anti-Inflammatory drug
  • Analgesic
  • Anaesthetic
  • By Formulation
  • Oral
  • Topical
  • By Distribution Channel:
  • Hospital
  • Retail pharmacies
  • Online pharmacies
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Drug Type :
  • Antibiotics
  • Nonsteroidal anti-Inflammatory drug
  • Analgesic
  • Anaesthetic
  • By Formulation
  • Oral
  • Topical
  • By Distribution Channel:
  • Hospital
  • Retail pharmacies
  • Online pharmacies
  • By Country:
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
  • Pfizer, Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Eli Lilly and Company
  • Abbott Laboratories
  • GlaxoSmithKline plc.
  • Bayer AG
  • Novartis AG
  • Pediapharm Inc.
  • Sanofi S.A.
  • Bristol Myers Squibb Company
  •  “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
    • Market Definition and Scope
    • Executive Summary
    • Market Snippet, By Drug Type
    • Market Snippet, By Formulation
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Technological Trends
    • Unmet Needs
    • Regulatory Scenario
    • Recent Product Approvals/Launch
    • Technological Advancement
    • PEST Analysis
    • Porter's Five Forces Analysis

4. Global Acute Otitis Media Treatment Market, By Drug Type, 2016-2025 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2016-2025
    • Segment Trends
    • Antibiotics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
    • Nonsteroidal anti-Inflammatory drug
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
    • Analgesic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
    • Anaesthetic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)

5. Global Acute Otitis Media Treatment Market, By Formulation, 2017-2025 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2016-2025
    • Segment Trends
    • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
    • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)

6. Global Acute Otitis Media Treatment Market, By Distribution Channel, 2016-2025 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2016-2025
    • Segment Trends
    • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
    • Retail pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
    • Online pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)

7. Global Acute Otitis Media Treatment Market, By Region, 2016-2025 (US$ Mn)

    • Introduction
    • Market Share Analysis, By Region, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, For Regions, 2016-2025
    • North America
    • Market Size and Forecast, By Drug Type, 2015-2025 (US$ Mn)
    • Market Size and Forecast, By Formulation, 2015-2025 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel , 2015-2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
    • U.S.
    • Canada
    • Europe
    • Market Size and Forecast, By Drug Type, 2015-2025 (US$ Mn)
    • Market Size and Forecast, By Formulation, 2015-2025 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel , 2015-2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • Market Size and Forecast, By Drug Type, 2015-2025 (US$ Mn)
    • Market Size and Forecast, By Formulation, 2015-2025 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel , 2015-2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of APAC
    • Latin America
    • Market Size and Forecast, By Drug Type, 2015-2025 (US$ Mn)
    • Market Size and Forecast, By Formulation, 2015-2025 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel , 2015-2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Africa
    • Market Size and Forecast, By Drug Type, 2015-2025 (US$ Mn)
    • Market Size and Forecast, By Formulation, 2015-2025 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel , 2015-2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
    • Central Africa
    • South Africa
    • North Africa
    • Middle East
    • Market Size and Forecast, By Drug Type, 2015-2025 (US$ Mn)
    • Market Size and Forecast, By Formulation, 2015-2025 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel , 2015-2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East

8. Competitive Landscape

    • Heat Map Analysis
    • Company Profiles
    • Pfizer, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Eli Lilly and Company
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • GlaxoSmithKline plc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Bayer AG
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Novartis AG
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Pediapharm Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Sanofi S.A.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Bristol Myers Squibb Company
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

    • References
    • Research Methodology
    • About us and Sales Contact